| Yung Shin Pharma (YSP) and ICE Pharma Group (ICE) are working in a strategic partnership to secure YSP as the first manufacturer in Taiwan to gain EU GMP approval status. YSP is the largest generic pharmaceutical companies in Taiwan, with vertically integrated facilities from APIs through to finished products. YSP has US FDA approval for facilities in Taiwan, China as well as its US subsidiary, its strategic goal is to enter the EU market, ICE has been working closely with YSP to prepare the premises for EU inspection and it is expected that an EU inspection will happen in 2010. |
1. CPhI
I Active Pharmaceutical ingredients except medicinal plants, plant/animal extracts and herbal teas
Active Pharmaceutical Ingredients (general category)
Antibiotics
III Excipients and Drug Formulation
Excipients and Drug Formulation (general category)
V General
Custom manufacturing (general category)
|
|
|